Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Effect of partial hepatectomy on in vivo engraftment after intravenous administration of human adipose tissue stromal cells in mouse.

Kim DH., Je CM., Sin JY., Jung JS.

Animal Study on Systemic / IV, published in Microsurgery (2003) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Microsurgery (2003)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
14557995
DOI
10.1002/micr.10178

Abstract (original English)

Their multidifferentiation potential makes human mesenchymal stem cells (hMSCs) candidates for cell-based therapeutic strategies for tissue injuries and for hematopoietic disorders by both local and systemic application. Despite their potential clinical utility in cellular and gene therapy, the fate of adipose stromal cells (ATSCs) after systemic administration is mostly unknown. In this study, we investigated the distribution of ATSCs injected intravenously and the effect of partial hepatectomy on their distribution. Adipose tissue stromal cells (hATSCs) were obtained from adipose tissues of adult human donors. Under appropriate culture conditions, hATSCs were induced to differentiate into osteocytes and adipocyte lineages. The hATSCs were marked by infection with the lacZ-adeno virus, and the distribution of injected cells was examined by X-Gal staining. Immunosuppression was achieved by the administration of cyclosporin into mice. The hATSCs were engrafted onto various tissues, including brain, thymus, heart, liver, and lung, after intravenous administration. Liver regeneration induced by partial hepatectomy enhanced the integration of hATCSCs into the liver. These results demonstrate that hATSCs have the ability to proliferate extensively in culture, and that they maintain their multilineage differentiation potential in vitro, establishing their progenitor cell nature. Thes

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueAdultAnimalsCells, CulturedHepatectomyHumansInjections, IntravenousLiver RegenerationMesenchymal Stem Cell TransplantationMesenchymal Stem Cells

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research